Since 2007, the Fair Haven Community Health Care’s Diabetes Prevention Program (DPP) has offered 1-hour healthy lifestyle class once per week for participants in the 12-week Intensive Lifestyle Intervention. The healthy lifestyle program curriculum is based on the National Institutes of Health’s Diabetes Prevention Program curriculum, amended by the University of Pittsburgh to fit larger groups, and further translated to fit Fair Haven’s particularly predominant Latino population. Classes are taught by Fair Haven DPP clinicians and are delivered in both English and Spanish. Bilingual presentations and handouts guide the learning for each session, while facilitators address the diverse needs and experiences of the participants.
Cooking demonstrations and discussions are an experiential learning component of each class, and foods prepared each week reflect the ripe produce harvested that week from the program’s garden. Between 15-20 adults attend classes on a weekly basis, and often that same group stays the next hour for a professional trainer-led exercise class. Children attend their own exercise classes during the adult nutrition and exercise classes, while infants and toddlers attend onsite childcare. Aligned with the notion that diabetes is a family-oriented disease, when one patient is invited to attend nutrition classes, the DPP staff invites members of the patient’s family to attend as well.
Bright Bodies is a weight management program for children ages 7 to 16 that involves nutrition education, behavior modification and exercise in a family setting. Children and their families attend class once a week and exercise three times a week. This program is run in conjunction with the Diabetes Prevention Program as the clinic works to combat obesity and diabetes with lifestyle changes for entire families.
Fair Haven, along with the Yale School of Medicine is participating in a grant-supported medical research study comparing different diabetes treatments. Fair Haven’s Diabetes Prevention Program (DPP), led by national principal co-investigator endocrinologist Dr. Anne Camp, along with Yale, participated in a competitive grant application and was one of 40+ sites nationally to be awarded the National Institute of Health (NIH) grant to conduct the GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness) Study. This study is an exciting because it seeks to evaluate what the most effective combination of treatments for patients with diabetes is, rather than pure drug experimentation treatment.
The goal is to find out which diabetes medicines work best for people who are over age 30, have type 2 diabetes diagnosed within the last ten years and are treated with Metformin–the first line gold standard diabetes treatment. The study compares four medications that providers at Fair Haven are already providing, plus Metformin. Participants were recruited over a period of three years and are receiving their diabetes medication free of charge during the duration of the study (which runs through 2021).
Fair Haven’s DPP program is honored join Yale School of Medicine and the NIH to participate in this study.
To see information regarding this study from the NIH, please click here.